The new BMJ policy on sharing data from drug and device trials

BMJ (Online)

Volumn 345, Issue 7884, 2012, Pages

  Godlee, Fiona ^a   Groves, Trish ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; OSELTAMIVIR; ZANAMIVIR;

CLINICAL RESEARCH; DATA BASE; DRUG INDUSTRY; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH SERVICE; HUMAN; MEDICAL DECISION MAKING; MEDICAL DEVICE; MEDICAL INFORMATION; MEDICAL LITERATURE; PATIENT CARE; POLICY; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; REPRODUCIBILITY; RESPONSIBILITY;

CLINICAL TRIALS AS TOPIC; EQUIPMENT AND SUPPLIES; GREAT BRITAIN; INFORMATION DISSEMINATION; PERIODICALS AS TOPIC; PHARMACEUTICAL PREPARATIONS; PUBLISHING;

EID: 84869835629     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e7888     Document Type: Editorial

References (15)

1. Godlee F. Clinical trial data for all drugs in current use. BMJ 2012;345:e7304.
2. Prayle AP, Hurley MN, Smyth AR. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ 2012;344:d7373.
3. Rathi V, Dzara K, Gross CP, Hrynaszkiewicz I, Joffe S, Krumholz AM, et al. Sharing of clinical trial data among trialists: a cross sectional survey. BMJ 2012;345:e7570.
4. Wirotsko BM, Tressler C, Hwang L-J, Burgess G, Laties AM. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III randomised, double masked placebo controlled trial and open label extension. BMJ 2012;344:e554.
5. Annals of Internal Medicine. Information for authors: reproducible research. http://annals.org/public/authorsinfo.aspx#research-publication-ethics.
6. PLOS Medicine. PLOS editorial and publishing policies: sharing of materials, methods, and data. www.plosmedicine.org/static/policies. action;jsessionid=0CD27C4DE9841485620ED21B9E815D54#sharing.
7. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med 2009;6(9):e1000144.
8. Gotzsche P, Jorgensen AW. Opening up data at the European Medicines Agency. BMJ 2011;342:d2686.
9. Eichler H-G, Abadie E, Breckenridge A, Leufkens H, Rasi G. Open clinical trial data for all? A view from regulators. PLoS Med 2012;9(4):e1001202.
10. European Medicines Agency. European regulators propose way forward for publication of full clinical-trial data. 11 Apr 2012. www.ema.europa.eu/ema/ index.jsp?curl=pages/news-and-events/news/2012/04/news-detail-001486. jsp&mid=WC0b01ac058004d5c1.
11. Yale School of Medicine. Yale University open data access (YODA) project. http://medicine.yale.edu/core/projects/yodap/medtronic-data/medtronic-data. aspx.
12. Wilbanks J. YODA yada yada. 15 Nov 2012. http://del-fi.org/post/ 35828082548/yodayada-yada.
13. Payne D. Tamiflu: the battle for secret drug data. BMJ 2012;345:e7303.
14. Medicines and Healthcare Products Regulatory Agency. What is a medicine? www.mhra.gov.uk/Howweregulate/Medicines/Doesmyproductneedalicence/ Borderlineproducts/index.htm#l1.
15. Food and Drug Administration. Medical devices: premarket approval (PMA). www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/ PremarketSubmissions/PremarketApprovalPMA/default.htm.